Vaxart, Inc. VXRT
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -85.33% | -31.58% | 87.90% | 586.46% | 1,367.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -85.33% | -31.58% | 87.90% | 586.46% | 1,367.93% |
| Cost of Revenue | -69.94% | -32.13% | -4.33% | 99.30% | 404.10% |
| Gross Profit | -245.47% | 34.34% | 199.45% | 891.12% | 65.12% |
| SG&A Expenses | 18.63% | 43.61% | -8.41% | -8.87% | -1.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -65.22% | -25.72% | -4.91% | 82.99% | 313.36% |
| Operating Income | -121.26% | 9.80% | 134.64% | 582.27% | 46.04% |
| Income Before Tax | -113.90% | 10.03% | 133.61% | 569.04% | 42.23% |
| Income Tax Expenses | 1,735.29% | 45.00% | -69.47% | 95.45% | -5.56% |
| Earnings from Continuing Operations | -117.28% | 9.96% | 133.22% | 559.28% | 42.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -117.28% | 9.96% | 133.22% | 559.28% | 42.18% |
| EBIT | -121.26% | 9.80% | 134.64% | 582.27% | 46.04% |
| EBITDA | -179.38% | -0.20% | 149.65% | 720.98% | 53.22% |
| EPS Basic | -104.49% | 15.09% | 131.43% | 542.88% | 42.49% |
| Normalized Basic EPS | -101.35% | 15.12% | 131.76% | 553.09% | 42.49% |
| EPS Diluted | -104.49% | 15.09% | 128.57% | 540.61% | 42.49% |
| Normalized Diluted EPS | -101.35% | 15.12% | 131.53% | 552.47% | 42.49% |
| Average Basic Shares Outstanding | 6.21% | 6.04% | 5.58% | 3.64% | 0.65% |
| Average Diluted Shares Outstanding | 6.21% | 6.04% | 6.26% | 3.77% | 0.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |